Regulation of p53 stability - PubMed

Affiliations

• PMID: 10618703
• DOI: 10.1038/sj.onc.1203012

Review

Regulation of p53 stability

M Ashcroft et al. Oncogene. 1999.

Abstract

Leading the way in imposing a policy of zero tolerance of cellular abnormalities that might lead to tumor development is the p53 protein. The efficiency of p53 in preventing cell growth is a strong deterrent to malignant progression, but this activity must be kept tightly restrained to allow normal cell growth and development. Essential components of this regulation are the mechanisms by which the p53 protein is degraded, and efficient turnover of p53 in normal cells prevents the accumulation of the protein. Modulation of these degradation pathways in response to stress leads to the rapid stabilization and accumulation of p53, and activation of the p53 response. It is now becoming clear that the Mdm2 protein is central to the regulation of p53 stability and multiple pathways exist through which the activity of Mdm2 can be inhibited. Defects in the ability to stabilize p53 are likely to contribute to malignant development, and restoration of this activity represents an extremely attractive possibility for tumor therapy.

Similar articles

• Activation and activities of the p53 tumour suppressor protein.

  Bálint E E, Vousden KH. Bálint E E, et al. Br J Cancer. 2001 Dec 14;85(12):1813-23. doi: 10.1054/bjoc.2001.2128. Br J Cancer. 2001. PMID: 11747320 Free PMC article. Review.

• Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.

  Honda R, Yasuda H. Honda R, et al. EMBO J. 1999 Jan 4;18(1):22-7. doi: 10.1093/emboj/18.1.22. EMBO J. 1999. PMID: 9878046 Free PMC article.

• p19ARF prevents G1 cyclin-dependent kinase activation by interacting with MDM2 and activating p53 in mouse fibroblasts.

  Kurokawa K, Tanaka T, Kato J. Kurokawa K, et al. Oncogene. 1999 Apr 29;18(17):2718-27. doi: 10.1038/sj.onc.1202628. Oncogene. 1999. PMID: 10348346

• Regulation of p53 stability by Mdm2.

  Kubbutat MH, Jones SN, Vousden KH. Kubbutat MH, et al. Nature. 1997 May 15;387(6630):299-303. doi: 10.1038/387299a0. Nature. 1997. PMID: 9153396

• [When p19ARF finds a partner or new "dangerous liaisons"].

  Larsen CJ. Larsen CJ. Bull Cancer. 1998 Jun;85(6):523-6. Bull Cancer. 1998. PMID: 9752279 Review. French.

Cited by

• Modulation of the p38 MAPK (mitogen-activated protein kinase) pathway through Bcr/Abl: implications in the cellular response to Ara-C.

  Sánchez-Arévalo Lobo VJ, Aceves Luquero CI, Alvarez-Vallina L, Tipping AJ, Viniegra JG, Hernández Losa J, Parada Cobo C, Galán Moya EM, Gayoso Cruz J, Melo JV, Ramón y Cajal S, Sánchez-Prieto R. Sánchez-Arévalo Lobo VJ, et al. Biochem J. 2005 Apr 1;387(Pt 1):231-8. doi: 10.1042/BJ20040927. Biochem J. 2005. PMID: 15540985 Free PMC article.

• Glioblastoma cells inhibit astrocytic p53-expression favoring cancer malignancy.

  Biasoli D, Sobrinho MF, da Fonseca AC, de Matos DG, Romão L, de Moraes Maciel R, Rehen SK, Moura-Neto V, Borges HL, Lima FR. Biasoli D, et al. Oncogenesis. 2014 Oct 20;3(10):e123. doi: 10.1038/oncsis.2014.36. Oncogenesis. 2014. PMID: 25329722 Free PMC article.

• Subfunctionalized expression drives evolutionary retention of ribosomal protein paralogs Rps27 and Rps27l in vertebrates.

  Xu AF, Molinuevo R, Fazzari E, Tom H, Zhang Z, Menendez J, Casey KM, Ruggero D, Hinck L, Pritchard JK, Barna M. Xu AF, et al. Elife. 2023 Jun 12;12:e78695. doi: 10.7554/eLife.78695. Elife. 2023. PMID: 37306301 Free PMC article.

• p53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells.

  Jain AK, Allton K, Iacovino M, Mahen E, Milczarek RJ, Zwaka TP, Kyba M, Barton MC. Jain AK, et al. PLoS Biol. 2012;10(2):e1001268. doi: 10.1371/journal.pbio.1001268. Epub 2012 Feb 28. PLoS Biol. 2012. PMID: 22389628 Free PMC article.

• Loss of Glis2/NPHP7 causes kidney epithelial cell senescence and suppresses cyst growth in the Kif3a mouse model of cystic kidney disease.

  Lu D, Rauhauser A, Li B, Ren C, McEnery K, Zhu J, Chaki M, Vadnagara K, Elhadi S, Jetten AM, Igarashi P, Attanasio M. Lu D, et al. Kidney Int. 2016 Jun;89(6):1307-23. doi: 10.1016/j.kint.2016.03.006. Kidney Int. 2016. PMID: 27181777 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database

• Research Materials

  • NCI CPTC Antibody Characterization Program

• Miscellaneous

  • NCI CPTAC Assay Portal